Kaneta S, Jinno Y, Harada K, Fukushima H, Ogawa N
Pharmaceutical Research Laboratory, Kirin Brewery Co., Ltd., Gunma, Japan.
Arch Int Pharmacodyn Ther. 1992 Jul-Aug;318:21-35.
We examined whether KRN2391, isosorbide dinitrate and nitroglycerin induced tolerance in coronary arteries. Intracoronary arterial administration of KRN2391 (1 microgram), isosorbide dinitrate (30 micrograms) or nitroglycerin (3 micrograms) produced equipotent coronary vasodilatation. Development of tolerance was determined by whether the increase in coronary blood flow, caused by intracoronary arterial administration of these drugs, was attenuated by intravenous infusion of KRN2391, isosorbide dinitrate or nitroglycerin. The increase in coronary blood flow, caused by intracoronary arterial administration of KRN2391 was not affected by intravenous infusion of KRN2391 (0.3 or 1 micrograms/kg/min), isosorbide dinitrate (30 or 100 micrograms/kg/min) or nitroglycerin (1 or 3 micrograms/kg/min). The increase in coronary blood flow, caused by intracoronary arterial administration of isosorbide dinitrate or nitroglycerin, was significantly diminished by intravenous infusion of isosorbide dinitrate and nitroglycerin, but was unaffected by intravenous infusion of KRN2391. The present results suggest that KRN2391 does not induce acute tolerance by itself or cross-tolerance between KRN2391 and other nitrates.
我们研究了KRN2391、异山梨醇二硝酸酯和硝酸甘油是否会在冠状动脉中诱导耐受性。冠状动脉内给予KRN2391(1微克)、异山梨醇二硝酸酯(30微克)或硝酸甘油(3微克)可产生等效的冠状动脉血管舒张作用。耐受性的发展取决于冠状动脉内给予这些药物所引起的冠状动脉血流量增加是否会因静脉输注KRN2391、异山梨醇二硝酸酯或硝酸甘油而减弱。冠状动脉内给予KRN2391所引起的冠状动脉血流量增加不受静脉输注KRN2391(0.3或1微克/千克/分钟)、异山梨醇二硝酸酯(30或100微克/千克/分钟)或硝酸甘油(1或3微克/千克/分钟)的影响。冠状动脉内给予异山梨醇二硝酸酯或硝酸甘油所引起的冠状动脉血流量增加会因静脉输注异山梨醇二硝酸酯和硝酸甘油而显著减少,但不受静脉输注KRN2391的影响。目前的结果表明,KRN2391本身不会诱导急性耐受性,也不会在KRN2391与其他硝酸盐之间诱导交叉耐受性。